FR2401162B1 - - Google Patents

Info

Publication number
FR2401162B1
FR2401162B1 FR7806154A FR7806154A FR2401162B1 FR 2401162 B1 FR2401162 B1 FR 2401162B1 FR 7806154 A FR7806154 A FR 7806154A FR 7806154 A FR7806154 A FR 7806154A FR 2401162 B1 FR2401162 B1 FR 2401162B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7806154A
Other languages
French (fr)
Other versions
FR2401162A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9366/77A external-priority patent/GB1601688A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2401162A1 publication Critical patent/FR2401162A1/fr
Application granted granted Critical
Publication of FR2401162B1 publication Critical patent/FR2401162B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7806154A 1977-03-05 1978-03-03 Antibiotique derive d'un streptomyces, utilisable comme medicament Granted FR2401162A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9366/77A GB1601688A (en) 1977-03-05 1977-03-05 6-(1-hydroxyethyl)-7-oxo 1-aza bicyclo (3,2,0)-hept-2-ene-2-carboxylic acid derivatives and their use in pharmaceutical compositions
GB3283677 1977-08-05

Publications (2)

Publication Number Publication Date
FR2401162A1 FR2401162A1 (fr) 1979-03-23
FR2401162B1 true FR2401162B1 (es) 1980-08-29

Family

ID=26242889

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806154A Granted FR2401162A1 (fr) 1977-03-05 1978-03-03 Antibiotique derive d'un streptomyces, utilisable comme medicament

Country Status (11)

Country Link
JP (1) JPS53116396A (es)
AU (1) AU525142B2 (es)
CH (1) CH641805A5 (es)
DE (1) DE2808563A1 (es)
DK (1) DK98478A (es)
ES (1) ES467562A1 (es)
FR (1) FR2401162A1 (es)
IE (1) IE46736B1 (es)
IT (1) IT7848280A0 (es)
NL (1) NL7802356A (es)
SE (1) SE7802462L (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162323A (en) * 1977-04-18 1979-07-24 Merck & Co., Inc. Antibiotic N-acetyl-dehydro-thienamycin
DE2966446D1 (en) * 1978-09-09 1984-01-05 Beecham Group Plc Beta-lactam compounds, their preparation and use
EP0033209B1 (en) * 1980-01-25 1984-06-13 Beecham Group Plc Beta-lactam containing compounds, their preparation and use
IN155384B (es) * 1980-05-14 1985-01-19 Pfizer
JP4977670B2 (ja) * 2008-09-11 2012-07-18 啓司 関口 生花整形器

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK143713C (da) * 1975-11-21 1982-03-08 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof n-acetyl-thienamycin og salte deraf
DK143712C (da) * 1975-11-21 1982-03-22 Merck & Co Inc Fremgangsmaade til fremstilling af de antibiotiske stoffer 890a1 og 890a3
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.

Also Published As

Publication number Publication date
FR2401162A1 (fr) 1979-03-23
DE2808563A1 (de) 1978-09-07
IT7848280A0 (it) 1978-03-03
SE7802462L (sv) 1978-09-06
JPS53116396A (en) 1978-10-11
AU525142B2 (en) 1982-10-21
AU3384178A (en) 1979-09-06
IE46736B1 (en) 1983-09-07
ES467562A1 (es) 1980-05-16
DK98478A (da) 1978-09-06
CH641805A5 (en) 1984-03-15
IE780443L (en) 1978-09-05
NL7802356A (nl) 1978-09-07

Similar Documents

Publication Publication Date Title
FR2378271B1 (es)
FR2387984B1 (es)
FR2378372B1 (es)
FR2376729B1 (es)
FR2377922B1 (es)
FR2401162B1 (es)
FR2378856B3 (es)
FR2376361B1 (es)
FR2377600B1 (es)
FR2348684B1 (es)
DK420577A (es)
BG25837A1 (es)
BG25822A1 (es)
BG25834A1 (es)
BG25829A1 (es)
BG25828A1 (es)
BG25827A2 (es)
BG25860A1 (es)
BG25826A1 (es)
BG25838A1 (es)
BG25839A1 (es)
BG25840A1 (es)
BG25841A1 (es)
BG25844A1 (es)
BG25845A1 (es)

Legal Events

Date Code Title Description
ST Notification of lapse